Cart
sales@molnova.com
NS11021
CAS No. 956014-19-0
NS11021( NS 11021 )
Catalog No. M25011 CAS No. 956014-19-0
NS11021, a novel opener of large-conductance Ca(2+)-activated K(+) channels.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 91 | In Stock |
|
| 5MG | 81 | In Stock |
|
| 10MG | 130 | In Stock |
|
| 25MG | 277 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 786 | In Stock |
|
| 200MG | 1051 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNS11021
-
NoteResearch use only, not for human use.
-
Brief DescriptionNS11021, a novel opener of large-conductance Ca(2+)-activated K(+) channels.
-
DescriptionNS11021, a novel opener of large-conductance Ca(2+)-activated K(+) channels.
-
In Vitro——
-
In Vivo——
-
SynonymsNS 11021
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number956014-19-0
-
Formula Weight511.24
-
Molecular FormulaC16H9BrF6N6S
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL (489.01 mM; Need ultrasonic)
-
SMILESFC(c1cc(NC(Nc(ccc(Br)c2)c2-c2n[nH]nn2)=S)cc(C(F)(F)F)c1)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kun A , Matchkov V V , Stankevicius E , et al. NS11021, a novel opener of large-conductance Ca(2+)-activated K(+) channels, enhances erectile responses in rats[J]. British Journal of Pharmacology, 2010, 158(6):1465-1476.
molnova catalog
related products
-
GAL-021 sulfate
GAL-021 sulfate is a BKCa channel blocker that inhibits the analgesic effects of opioids and is used in the study of respiratory control diseases.
-
ICA 110381
ICA 110381 is a KCNQ2/Q3 potassium channel opener for the treatment of epilepsy.
-
Aprikalim
Aprikalim (RP 52891) is an adenosine triphosphate potassium channel (KATP) opener that protects against nerve damage in a rabbit model of spinal cord ischemia.Aprikalim inhibits vasoconstriction and inhibits the elevation of [Ca2+]i during myocardial paralysis, and can be used to study cardiovascular disease.
